Overcoming barriers to hepatitis C treatment among substance users


Marija Zeremski, PhD,

Project Director, Clinical Directors Network (CDN)

A live webcast sponsored by:

Merck (Grant No. AAN170209041806), The N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667) and Clinical Directors Network, Inc. (CDN)

Summary of Session Goals:

Substance users have the highest prevalence of hepatitis C virus (HCV) infection but are very rarely treated. Despite recent approval of HCV treatment regimens with almost universal efficacy, complete eradication of HCV will not be possible before all patient populations have access to treatment. In this webcast we will:


Monday, October 2, 2017 from 1:00 PM to 2:30 PM EDT


Overcoming Barriers to Hepatitis C Treatment Among Substance Users (PDF)

This activity has been reviewed and approved for up to 1.5 Prescribed credit(s) by the American Academy of Family Physicians (AAFP).

Please Click Here to complete the evaluation for enduring CME credits, which are ANCC recognized.

Recent Webcasts

Partnering with Community to Improve Health

Mary Brown Walker, DHA, MSN-APN
Director of Nursing, Friend Family Health Center
Claire Kohrman, PhD
Consultant, Community Research and Training...

Intersection of Quality Improvement (QI) and Research

Lisa Hirschhorn, MD, MPH,
Professor of Medical Social Sciences and Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine
Thursday, October 5, 2017...